HCG Borivali Showcases Future of Cancer Care with ROBOCAN 1.0
Mumbai (Maharashtra) [India], April 22: HCG Cancer Hospital, Borivali, Mumbai successfully hosted ROBOCAN 1.0, a Continuing Medical Education (CME) session on “Robotic Surgery: Redefining Cancer Care with Robotic Excellence.” The event brought together leading oncologists, surgeons, and healthcare professionals to discuss the growing role of robotic-assisted surgery in enhancing cancer care.
The session aimed to strengthen clinical understanding and promote the adoption of minimally invasive, precision-driven surgical techniques. With limited access to advanced oncology technologies in parts of Mumbai’s western suburbs, the initiative served as an important platform to bridge knowledge gaps and introduce next-generation surgical approaches.
The scientific discussions spanned multiple specialties, including urology, head & neck cancers, gastrointestinal cancers, and gynecological oncology. Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery, thereby significantly enhancing patient outcomes and quality of life.
Speaking at the session, Dr. Saket Sathe, Consultant – Uro Oncology & Robotic Surgery, HCG Cancer Hospital, Borivali said, “Robotic surgery has transformed the management of urological cancers by offering superior precision, reduced complications, and quicker recovery, ultimately improving patient outcomes.”
Dr. Chandrakant Pancholi, Consultant – Uro Oncology & Robotic Surgery, HCG Cancer Hospital, Borivali added, “The transition to robotic-assisted procedures is not just technological but transformational, enabling safer and more effective surgical interventions.”
Highlighting its expanding scope, Dr. Tirathram Kaushik, Consultant – GI, HPB, Gynecological & Thoracic Oncology & Robotic Surgery, HCG Cancer Hospital, Borivali noted that robotic surgery is increasingly enabling safer and more precise interventions even in complex and anatomically challenging cases.
The CME also spotlighted advancements in head and neck oncology, particularly the Bilateral Axillo-Breast Approach (BABA) technique, which enables scarless surgeries with improved cosmetic and functional outcomes. Dr. Yash Mathur, Senior Consultant – Head & Neck Oncology & Robotic Surgery, HCG Cancer Hospital emphasized that such innovations help reduce post-surgical disfigurement while preserving patient confidence.
Mr. Avik Chauhan, Cluster Chief Operating Officer, Mumbai, said, HCG Cancer Hospital,Mumbai“Robotic surgery is a significant step forward in making cancer treatment more precise and patient-friendly. At HCG, we are committed to bringing such advanced technologies closer to patients and ensuring better clinical outcomes through continuous innovation.”
The event concluded with a multidisciplinary panel discussion on the expanding role of robotics in cancer care. Over the past two years, the Hospital has completed more than 200 robotic cancer surgeries, reflecting its growing expertise in advanced oncology care.
Through initiatives like ROBOCAN 1.0, HCG Cancer Hospital, Borivali continues to drive innovation, education, and excellence in cancer treatment.
About HCG Cancer Hospital Borivali
Part of the renowned HCG network, HCG Cancer Hospital Borivali is a leading cancer care facility in Mumbai, offering advanced therapies including robotic surgery, radiation, and chemotherapy. With cutting-edge technology and a team of expert oncologists, the center ensures precise treatment and improved patient outcomes. Beyond clinical care, HCG Borivali provides holistic support, including counseling, nutritional guidance, and rehabilitation, fostering a compassionate environment for patients and families.
If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.
